Table 2. . Examining the association between PRO collection and outcomes of interest among matched patients.
| Strata | Outcome | Measure of effect | Estimate | Lower 95% CI | Upper 95% CI | p-value |
|---|---|---|---|---|---|---|
| Overall | OS | HR | 1.01 | 0.93 | 1.09 | 0.836 |
| TTNT | HR | 1.03 | 0.94 | 1.11 | 0.56 | |
| Total HCRU | MD | 0.29 | -0.20 | 0.78 | 0.248 | |
| Treatment discontinuation | OR | 0.98 | 0.85 | 1.12 | 0.75 | |
| Cancer physician visits | MD | -1.04 | -1.29 | -0.78 | <0.001 | |
| Outpatient ambulatory care encounters | MD | 1.12 | 0.77 | 1.46 | <0.001 | |
| Hospitalization | OR | 1.12 | 1.03 | 1.22 | 0.01 | |
| ER Visits | OR | 1.10 | 1.01 | 1.19 | 0.024 |
ER: Emergency room; HCRU: Healthcare resource utilization; HR: Hazard ratio; MD: Mean difference; OR: Odds ratio; OS: Overall survival; TTNT: Time to next treatment.